Ypsomed Holding AG (YPSN) - Total Liabilities
Based on the latest financial reports, Ypsomed Holding AG (YPSN) has total liabilities worth CHF401.49 Million CHF (≈ $507.59 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore YPSN net assets growth trend to track the company's year-over-year net asset growth rate.
Ypsomed Holding AG - Total Liabilities Trend (2002–2025)
This chart illustrates how Ypsomed Holding AG's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Ypsomed Holding AG generate to measure how efficiently the company converts operating cash flow to free cash.
Ypsomed Holding AG Competitors by Total Liabilities
The table below lists competitors of Ypsomed Holding AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vontobel Holding
SW:VONN
|
Switzerland | CHF32.26 Billion |
|
TRI Pointe Homes Inc
NYSE:TPH
|
USA | $1.71 Billion |
|
Lazard Ltd
NYSE:LAZ
|
USA | $3.95 Billion |
|
Patterson-UTI Energy Inc
NASDAQ:PTEN
|
USA | $2.19 Billion |
|
KRONES AG(UNSP.ADR)1/2/ON
F:KRNU
|
Germany | €2.79 Billion |
|
Sinotruk Jinan Truck Co Ltd
SHE:000951
|
China | CN¥38.06 Billion |
|
Jiangsu Aucksun Co Ltd
SHE:002245
|
China | CN¥5.12 Billion |
|
Jiangxi Zhengbang Technology Co Ltd
SHE:002157
|
China | CN¥9.41 Billion |
Liability Composition Analysis (2002–2025)
This chart breaks down Ypsomed Holding AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Ypsomed Holding AG (YPSN) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.14 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ypsomed Holding AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ypsomed Holding AG (2002–2025)
The table below shows the annual total liabilities of Ypsomed Holding AG from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | CHF650.66 Million ≈ $822.61 Million |
+34.53% |
| 2024-03-31 | CHF483.66 Million ≈ $611.48 Million |
+61.46% |
| 2023-03-31 | CHF299.55 Million ≈ $378.71 Million |
-17.79% |
| 2022-03-31 | CHF364.37 Million ≈ $460.66 Million |
+13.05% |
| 2021-03-31 | CHF322.30 Million ≈ $407.47 Million |
+10.04% |
| 2020-03-31 | CHF292.89 Million ≈ $370.30 Million |
+40.18% |
| 2019-03-31 | CHF208.94 Million ≈ $264.16 Million |
+31.66% |
| 2018-03-31 | CHF158.70 Million ≈ $200.64 Million |
+32.24% |
| 2017-03-31 | CHF120.00 Million ≈ $151.72 Million |
-0.85% |
| 2016-03-31 | CHF121.03 Million ≈ $153.02 Million |
+0.38% |
| 2015-03-31 | CHF120.57 Million ≈ $152.44 Million |
-4.58% |
| 2014-03-31 | CHF126.37 Million ≈ $159.76 Million |
+1.56% |
| 2013-03-31 | CHF124.42 Million ≈ $157.30 Million |
+13.86% |
| 2012-03-31 | CHF109.27 Million ≈ $138.15 Million |
-19.99% |
| 2011-03-31 | CHF136.58 Million ≈ $172.67 Million |
+9.91% |
| 2010-03-31 | CHF124.27 Million ≈ $157.11 Million |
-36.33% |
| 2009-03-31 | CHF195.19 Million ≈ $246.77 Million |
-11.54% |
| 2008-03-31 | CHF220.65 Million ≈ $278.96 Million |
-5.20% |
| 2007-03-31 | CHF232.76 Million ≈ $294.27 Million |
-11.05% |
| 2006-03-31 | CHF261.69 Million ≈ $330.84 Million |
-13.15% |
| 2005-03-31 | CHF301.31 Million ≈ $380.94 Million |
-38.38% |
| 2004-03-31 | CHF488.94 Million ≈ $618.16 Million |
+1463.17% |
| 2003-03-31 | CHF31.28 Million ≈ $39.55 Million |
+45.22% |
| 2002-03-31 | CHF21.54 Million ≈ $27.23 Million |
-- |
About Ypsomed Holding AG
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable inje… Read more